| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.025 | 0.6 |